Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer

Những quyển sách tương tự

• Highlight report: Role of PD-L1 in never-smokers
  Bằng: Albrecht, Wiebke
  Được phát hành: (2019)
• Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma
  Bằng: Antonio Calles, et al.
  Được phát hành: (2015)
• Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations
  Bằng: Ogino, Atsuko, et al.
  Được phát hành: (2020)
• Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
  Bằng: Gainor, J. F., et al.
  Được phát hành: (2019)
• Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
  Bằng: Justin F. Gainor, et al.
  Được phát hành: (2020)